Targeting RET in Patients With <i>RET</i>-Rearranged Lung Cancers: Results From the Global, Multicenter <i>RET</i> RegistryOliver Gautschi, Alexander Drilon, Julie Milia et al.|Journal of Clinical Oncology|2017Cited by 357
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumorsDennis Plenker, Martin L. Sos, Oliver Pagel et al.|Science Translational Medicine|2017Cited by 64
First results from the RETgistry: A global consortium for the study of resistance to RET inhibition in <i>RET</i>-altered solid tumors.Alissa J. Cooper, Alexander Drilon, Julia Rotow et al.|Journal of Clinical Oncology|2023Cited by 8
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in <i>RET</i> -Altered Solid Tumors: Analysis of the RETgistry Global ConsortiumSarah Waliany, Jessica J. Lin, Alissa J. Cooper et al.|Clinical Cancer Research|2026Cited by 4
MA16.03 Global RET Registry (GLORY): Activity of RET-Directed Targeted Therapies in RET-Rearranged Lung CancersOliver Gautschi, Alexander Drilon, Julie Milia-Baron et al.|Journal of Thoracic Oncology|2017Cited by 2